Intercept Pharmaceuticals
€17.52
35
+€0+0% Tuesday 13:10
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
725.63M
P/E Ratio
2.91
Dividend Yield
-
Dividend
-
Earnings
6NovExpected
Expected EPS
-0.44
Actual EPS
-0.07
Financials
71.98%Profit Margin
Profitable271.47MRevenue
195.41MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow I4P.F. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination with ursodeoxycholic acid in adults. It is also developing Ocaliva for various indications, including nonalcoholic steatohepatitis; and other product candidates in various stages of clinical and preclinical development. The company has a license agreement with Aralez Pharmaceuticals Canada Inc. to develop and commercialize bezafibrate in the United States. It markets its products through an internal commercial organization and third-party distributors. The company was incorporated in 2002 and is headquartered in New York, New York.
Show more...
CEO
Mr. Jerome B. Durso
Employees
437
Country
US
ISIN
US45845P1084
WKN
000A1J5U0
Listings
0 Comments
Share your thoughts
FAQ
What is Intercept Pharmaceuticals stock price today?▼
The current price of I4P.F is €17.52 EUR — it has increased by +0% in the past 24 hours. Watch Intercept Pharmaceuticals stock price performance more closely on the chart.
What is Intercept Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Intercept Pharmaceuticals stocks are traded under the ticker I4P.F.
What is Intercept Pharmaceuticals market cap?▼
Today Intercept Pharmaceuticals has the market capitalization of 725.63M
What is Intercept Pharmaceuticals revenue for the last year?▼
Intercept Pharmaceuticals revenue for the last year amounts to 271.47M EUR.
What is Intercept Pharmaceuticals net income for the last year?▼
I4P.F net income for the last year is 195.41M EUR.
How many employees does Intercept Pharmaceuticals have?▼
As of April 03, 2026, the company has 437 employees.
In which sector is Intercept Pharmaceuticals located?▼
Intercept Pharmaceuticals operates in the Healthcare sector.
When did Intercept Pharmaceuticals complete a stock split?▼
Intercept Pharmaceuticals has not had any recent stock splits.
Where is Intercept Pharmaceuticals headquartered?▼
Intercept Pharmaceuticals is headquartered in New York, US.